HALOPERIDOL-A PRELIMINARY CLINICAL STUDY
Haloperidol appears to be an effective tranquilizer in schizophrenic reactions accompained by paranoid symptomatology, and in other mental illnesses where paranoid symptoms are prominent. Extrapyramidal tract symptoms occurred, but were easily controlled with anti-Parkinsonian medication.
Gespeichert in:
| Veröffentlicht in: | The American journal of psychiatry 1965-10, Vol.122 (4), p.462-463 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 463 |
|---|---|
| container_issue | 4 |
| container_start_page | 462 |
| container_title | The American journal of psychiatry |
| container_volume | 122 |
| creator | HOLSTEIN, ARTHUR P CHEN, CALVIN H |
| description | Haloperidol appears to be an effective tranquilizer in schizophrenic reactions accompained by paranoid symptomatology, and in other mental illnesses where paranoid symptoms are prominent.
Extrapyramidal tract symptoms occurred, but were easily controlled with anti-Parkinsonian medication. |
| doi_str_mv | 10.1176/ajp.122.4.462 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1310593017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310593017</sourcerecordid><originalsourceid>FETCH-LOGICAL-a351t-7032010b505c37eff243c03ab182c97d7c9507a457aaee3f8d58734009e2ac563</originalsourceid><addsrcrecordid>eNptkEFLw0AQRhdRaq0ePQoFLyJsnN3JdJNjSKsNxLbUFuxp2SQbaLE2Js3Bf--WFvHgaRjm8X3DY-xWgCeEGjyZTeUJKT3f8wfyjHUFIXElZXDOugAgeUj4fsmummbjVkAlO6xDgSQfoMsexlE6nY3myXCa8qg_m4_S5DWZRPNVP06TSRJHaf9tsRyurtlFaT4ae3OaPbZ8Hi3iMU-nLweKGySx5wpQgoCMgHJUtiyljzmgyUQg81AVKg8JlPFJGWMtlkFBgUL3SmilyWmAPXZ_zK3q3Vdrm73e7Nr601VqgQIoRBDKUfxI5fWuaWpb6qpeb039rQXogxbttGinRfvaaXH83Sm1zba2-KVPHtz98Xg3VbX-0_hv2A-6DWTF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310593017</pqid></control><display><type>article</type><title>HALOPERIDOL-A PRELIMINARY CLINICAL STUDY</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>HOLSTEIN, ARTHUR P ; CHEN, CALVIN H</creator><creatorcontrib>HOLSTEIN, ARTHUR P ; CHEN, CALVIN H</creatorcontrib><description>Haloperidol appears to be an effective tranquilizer in schizophrenic reactions accompained by paranoid symptomatology, and in other mental illnesses where paranoid symptoms are prominent.
Extrapyramidal tract symptoms occurred, but were easily controlled with anti-Parkinsonian medication.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.122.4.462</identifier><identifier>PMID: 5825400</identifier><language>eng</language><publisher>United States: American Psychiatric Publishing</publisher><subject>Depressive Disorder, Major - drug therapy ; Extrapyramidal Tracts - drug effects ; Haloperidol - adverse effects ; Haloperidol - therapeutic use ; Humans ; Paranoid Disorders - drug therapy ; Schizophrenia - drug therapy ; Schizophrenia, Childhood - drug therapy ; Tranquilizing Agents - therapeutic use</subject><ispartof>The American journal of psychiatry, 1965-10, Vol.122 (4), p.462-463</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a351t-7032010b505c37eff243c03ab182c97d7c9507a457aaee3f8d58734009e2ac563</citedby><cites>FETCH-LOGICAL-a351t-7032010b505c37eff243c03ab182c97d7c9507a457aaee3f8d58734009e2ac563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.122.4.462$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.122.4.462$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2846,21608,27846,27901,27902,77534,77535</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5825400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HOLSTEIN, ARTHUR P</creatorcontrib><creatorcontrib>CHEN, CALVIN H</creatorcontrib><title>HALOPERIDOL-A PRELIMINARY CLINICAL STUDY</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Haloperidol appears to be an effective tranquilizer in schizophrenic reactions accompained by paranoid symptomatology, and in other mental illnesses where paranoid symptoms are prominent.
Extrapyramidal tract symptoms occurred, but were easily controlled with anti-Parkinsonian medication.</description><subject>Depressive Disorder, Major - drug therapy</subject><subject>Extrapyramidal Tracts - drug effects</subject><subject>Haloperidol - adverse effects</subject><subject>Haloperidol - therapeutic use</subject><subject>Humans</subject><subject>Paranoid Disorders - drug therapy</subject><subject>Schizophrenia - drug therapy</subject><subject>Schizophrenia, Childhood - drug therapy</subject><subject>Tranquilizing Agents - therapeutic use</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1965</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNptkEFLw0AQRhdRaq0ePQoFLyJsnN3JdJNjSKsNxLbUFuxp2SQbaLE2Js3Bf--WFvHgaRjm8X3DY-xWgCeEGjyZTeUJKT3f8wfyjHUFIXElZXDOugAgeUj4fsmummbjVkAlO6xDgSQfoMsexlE6nY3myXCa8qg_m4_S5DWZRPNVP06TSRJHaf9tsRyurtlFaT4ae3OaPbZ8Hi3iMU-nLweKGySx5wpQgoCMgHJUtiyljzmgyUQg81AVKg8JlPFJGWMtlkFBgUL3SmilyWmAPXZ_zK3q3Vdrm73e7Nr601VqgQIoRBDKUfxI5fWuaWpb6qpeb039rQXogxbttGinRfvaaXH83Sm1zba2-KVPHtz98Xg3VbX-0_hv2A-6DWTF</recordid><startdate>196510</startdate><enddate>196510</enddate><creator>HOLSTEIN, ARTHUR P</creator><creator>CHEN, CALVIN H</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope></search><sort><creationdate>196510</creationdate><title>HALOPERIDOL-A PRELIMINARY CLINICAL STUDY</title><author>HOLSTEIN, ARTHUR P ; CHEN, CALVIN H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a351t-7032010b505c37eff243c03ab182c97d7c9507a457aaee3f8d58734009e2ac563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1965</creationdate><topic>Depressive Disorder, Major - drug therapy</topic><topic>Extrapyramidal Tracts - drug effects</topic><topic>Haloperidol - adverse effects</topic><topic>Haloperidol - therapeutic use</topic><topic>Humans</topic><topic>Paranoid Disorders - drug therapy</topic><topic>Schizophrenia - drug therapy</topic><topic>Schizophrenia, Childhood - drug therapy</topic><topic>Tranquilizing Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOLSTEIN, ARTHUR P</creatorcontrib><creatorcontrib>CHEN, CALVIN H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOLSTEIN, ARTHUR P</au><au>CHEN, CALVIN H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HALOPERIDOL-A PRELIMINARY CLINICAL STUDY</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1965-10</date><risdate>1965</risdate><volume>122</volume><issue>4</issue><spage>462</spage><epage>463</epage><pages>462-463</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><abstract>Haloperidol appears to be an effective tranquilizer in schizophrenic reactions accompained by paranoid symptomatology, and in other mental illnesses where paranoid symptoms are prominent.
Extrapyramidal tract symptoms occurred, but were easily controlled with anti-Parkinsonian medication.</abstract><cop>United States</cop><pub>American Psychiatric Publishing</pub><pmid>5825400</pmid><doi>10.1176/ajp.122.4.462</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-953X |
| ispartof | The American journal of psychiatry, 1965-10, Vol.122 (4), p.462-463 |
| issn | 0002-953X 1535-7228 |
| language | eng |
| recordid | cdi_proquest_journals_1310593017 |
| source | MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
| subjects | Depressive Disorder, Major - drug therapy Extrapyramidal Tracts - drug effects Haloperidol - adverse effects Haloperidol - therapeutic use Humans Paranoid Disorders - drug therapy Schizophrenia - drug therapy Schizophrenia, Childhood - drug therapy Tranquilizing Agents - therapeutic use |
| title | HALOPERIDOL-A PRELIMINARY CLINICAL STUDY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HALOPERIDOL-A%20PRELIMINARY%20CLINICAL%20STUDY&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=HOLSTEIN,%20ARTHUR%20P&rft.date=1965-10&rft.volume=122&rft.issue=4&rft.spage=462&rft.epage=463&rft.pages=462-463&rft.issn=0002-953X&rft.eissn=1535-7228&rft_id=info:doi/10.1176/ajp.122.4.462&rft_dat=%3Cproquest_cross%3E1310593017%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310593017&rft_id=info:pmid/5825400&rfr_iscdi=true |